Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Christof Schultes"'
Autor:
Anja Seckinger, Hartmut Goldschmidt, Kai Neben, Dirk Hose, Bernd Janssen, Blanka Leber, Christof Schultes, Tobias Meißner, Uta Bertsch, Joe Lewis, Jens Hillengass, Bernard Klein, Karin Vanderkerken
Abstract 2987 Background. We have recently shown HIF1A to be expressed in 95.4% of CD138-purified myeloma cell samples from previously untreated patients (n= 329), with significantly higher [lower] expression in case of presence of t(4,14) [hyperdipl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84a2d7f4e6ffbd5f32f2e6c6663d4ec0
https://biblio.vub.ac.be/vubir/a-novel-class-of-sulfonanilides-entering-clinical-trials-for-targeted-treatment-of-multiple-myeloma-dualmechanism-compounds-inhibiting-hif1asignaling-and-inducing-apoptosis(702a5674-6251-49b0-80ff-fa4630a74f1b).html
https://biblio.vub.ac.be/vubir/a-novel-class-of-sulfonanilides-entering-clinical-trials-for-targeted-treatment-of-multiple-myeloma-dualmechanism-compounds-inhibiting-hif1asignaling-and-inducing-apoptosis(702a5674-6251-49b0-80ff-fa4630a74f1b).html
Autor:
A. Encinas-Lopez, J. D. Lewis, R. Thermann, D. Thomson, B. Janssen, M. Mülbaier, Brian Leber, J. Alonso, S. Wawro, Christof Schultes
Publikováno v:
European Journal of Cancer Supplements. 8:27
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9d1ca00112afaff1ff570d9bb3ac1e77
https://doi.org/10.1016/s1359-6349(10)71763-8
https://doi.org/10.1016/s1359-6349(10)71763-8
